
Aurinia Pharmaceuticals AUPH
$ 16.0
2.5%
Annual report 2025
added 02-26-2026
Aurinia Pharmaceuticals PEG Ratio 2011-2026 | AUPH
Annual PEG Ratio Aurinia Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.487 | -30 | -2.77 | -1.06 | -0.447 | -2.88 | 0.176 | -0.484 | 0.152 | 0.351 | 1.97 | 0.143 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.97 | -30 | -2.86 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioLineRx Ltd.
BLRX
|
1.32 | $ 2.25 | 1.81 % | $ 908 M | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 91.28 | 0.11 % | $ 27.2 B | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 330.34 | 3.6 % | $ 43.3 B | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
0.158 | $ 0.44 | -16.64 % | $ 5.04 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
0.304 | $ 24.98 | 1.17 % | $ 3.05 B | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
-0.0104 | $ 10.14 | -0.29 % | $ 135 M | ||
|
Cardiff Oncology
CRDF
|
0.185 | $ 1.58 | - | $ 106 M | ||
|
Curis
CRIS
|
-0.00281 | $ 0.53 | -3.07 % | $ 6.98 M | ||
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
Crinetics Pharmaceuticals
CRNX
|
-0.497 | $ 37.7 | 1.26 % | $ 3.55 B | ||
|
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 49.15 | -0.73 % | $ 4.42 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
-2.16 | $ 2.96 | -1.0 % | $ 252 M | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
CytomX Therapeutics
CTMX
|
0.413 | $ 4.4 | -3.51 % | $ 607 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Citius Pharmaceuticals
CTXR
|
-0.00125 | $ 0.86 | 0.67 % | $ 5.79 M | ||
|
Cue Biopharma
CUE
|
0.0442 | $ 0.18 | -1.61 % | $ 17.1 M | ||
|
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | ||
|
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.09 | -0.97 % | $ 437 M | ||
|
Cyclerion Therapeutics
CYCN
|
-0.0283 | $ 4.15 | -32.52 % | $ 10.4 M | ||
|
Daré Bioscience
DARE
|
-0.00777 | $ 1.81 | 4.02 % | $ 20.2 M | ||
|
DBV Technologies S.A.
DBVT
|
1.56 | $ 20.36 | -3.32 % | $ 2.84 B | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 8.22 | 2.37 % | $ 225 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Denali Therapeutics
DNLI
|
0.0706 | $ 19.38 | -6.15 % | $ 3.19 B | ||
|
Dyadic International
DYAI
|
0.649 | $ 0.87 | -2.8 % | $ 31.5 M | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
1.27 | $ 31.37 | 1.0 % | $ 2.08 B | ||
|
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M |